검색어 : 통합검색[Vaughn Margaret]
총 196건 중 196건 출력
, 19/20 페이지
-
181
- Impact of cisplatin-related adverse health outcomes (AHOs) on employment outcomes and self-reported health (SRH) among testicular cancer survivors (TCS).
- Kerns, Sarah L.; Fung, Chunkit; Fossa, Sophie D.; Dinh, Paul C; Monahan, Patrick O.; Sesso, Howard D.; Frisina, Robert D.; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Martin, Neil E.; Huddart, Robert A; Kollmannsberger, Christian K.; Sahasrabudhe, Deepak M.; Ardeshirrouhanifard, Shirin; Einhorn, Lawrence H.; Travis, Lois B.; University of Rochester Medical Center, Rochester, NY; ; University of Rochester Medical Center, Rochester, NY; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; University of South Florida, Tampa, FL; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute/Brigham & Women's Hospital, Boston, MA; ; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Surrey, United Kingdom; ; BC Cancer-Vancouver Cancer Centre, Vancouver, BC, Canada; ; Wilmot Cancer Center, Rochester, NY; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.37, 2019, pp.e16058-e16058)
-
182
- Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
- Trendowski, Matthew R.; El-Charif, Omar; Ratain, Mark J.; Monahan, Patrick; Mu, Zepeng; Wheeler, Heather E.; Dinh Jr, Paul C.; Feldman, Darren R.; Ardeshir-Rouhani-Fard, Shirin; Hamilton, Robert J.; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian; Mushiroda, Taisei; Kubo, Michiaki; Hannigan, Robyn; Strathmann, Frederick; Einhorn, Lawrence H.; Fossa, Sophie D.; Travis, Lois B.; Dolan, M. Eileen; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medicine, University of Chicago, Chicago, Illinois.; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, Illinois.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.; Division of Medical Oncology, University; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.25, 2019, pp.5913-5924)
-
183
- Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels.
- Shuey, Megan; Faucon, Annika; Trendowski, Matthew R.; Ratain, Mark J.; Dinh, Paul C; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian K.; Huddart, Robert A; Martin, Neil E.; Hannigan, Robyn; Einhorn, Lawrence H.; Travis, Lois B.; Dolan, M. Eileen; Cox, Nancy; Vanderbilt University Medical Center, Nashville, TN; ; Vanderbilt University, Nashville, TN; ; Department of Medicine, The University of Chicago, Chicago, IL; ; University of Chicago, Chicago, IL; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Department of Medicine, University of Pennsylvania, Philadelphia, PA; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; ; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; ; Dana Farber Cancer Institute, Boston, MA; ; Clarkson University, Potsdam, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Department of Me; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.12063-12063)
-
184
- Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: A multicenter study of North American testicular cancer survivors (TCS).
- Abu Zaid, Mohammad Issam; Menendez, Alvaro G.; El Charif, Omar; Fung, Chunkit; Monahan, Patrick O.; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Cook, Ryan; Althouse, Sandra K.; Sesso, Howard D.; Ardeshirrouhanifard, Shirin; Dinh, Paul C; Einhorn, Lawrence; Fosså , Sophie; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; The University of Chicago, Chicago, IL; ; University of Rochester Medical Center, Rochester, NY; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center, Philadelphia, PA; ; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; National Advisory Unit on Late Effects After Cancer Treatment, Oslo, Norway; ; Indiana University Scho; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.LBA10012-LBA10012)
-
185
- Variation in protein-coding sequence and the genetic basis of cisplatin-induced toxicities among testicular cancer survivors (TCS) in the Platinum Study.
- Gamazon, Eric R; Wheeler, Heather E.; Frisina, Robert D.; El Charif, Omar; Mushiroda, Taisei; Kubo, Michiaki; Ardeshir-Rouhani-Fard, Shirin; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair J.; Fung, Chunkit; Fossa, Sophie D.; Einhorn, Lawrence H.; Cox, Nancy; Dolan, M. Eileen; Travis, Lois B.; Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; ; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, IL; ; University of South Florida, Tampa, FL; ; The University of Chicago, Chicago, IL; ; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; ; RIKEN Center for Integrative Medical Science, Yokohama, Japan; ; School of Public Health, Indiana University, Bloomington, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Harvard University, Boston, MA; ; Wilmot Cancer Center, Rochester, NY; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Vanderbilt University, Nashville, TN; ; University of Chicago, Chicago, IL; ; Department of Medic; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.1537-1537)
-
186
- Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
- Wheeler, Heather E.; Gamazon, Eric R.; Frisina, Robert D.; Perez-Cervantes, Carlos; El Charif, Omar; Mapes, Brandon; Fossa, Sophie D.; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Beard, Clair J.; Fung, Chunkit; Kollmannsberger, Christian; Kim, Jeri; Mushiroda, Taisei; Kubo, Michiaki; Ardeshir-Rouhani-Fard, Shirin; Einhorn, Lawrence H.; Cox, Nancy J.; Dolan, M. Eileen; Travis, Lois B.; Department of Biology, Loyola University Chicago, Chicago, Illinois.; Division of Genetic Medicine, Vanderbilt University, Nashville, Tennessee.; Department of Chemical and Biomedical Engineering, University of South Florida, Tampa, Florida.; Department of Biology, Loyola University Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Oncology, Oslo University Hospital, Radiumhospital, Oslo, Norway.; Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.; Division of M; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.23, 2017, pp.3325-3333)
-
187
- Genome-wide association study (GWAS) of chemotherapy-induced Raynaud's phenomenon (RP) to reveal shared pathways with cardiovascular disease (CVD).
- El Charif, Omar; Wheeler, Heather E.; Trendowski, Matthew; Gamazon, Eric R; Ardeshirrouhanifard, Shirin; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Fung, Chunkit; Kim, Jeri; Fossa, Sophie D.; Abu Zaid, Mohammad Issam; Mushiroda, Taisei; Kubo, Michiaki; Einhorn, Lawrence H.; Cox, Nancy; Travis, Lois B.; Dolan, M. Eileen; The University of Chicago, Chicago, IL; ; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, IL; ; The University of Chicago, Chicago, IL; ; Vanderbilt University, Nashville, TN; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan-Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center, Philadelphia, PA; ; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; ; University of Rochester Medical Center, Rochester, NY; ; The University of Texas MD Anderson Cancer Center, Houston, TX; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University School of Medicine, Indianapolis, IN; ; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; ; RIKEN Center for Integrative Medical Science, Yokohama, Japan; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapol; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.e18162-e18162)
-
188
- Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.
- Ardeshirrouhanifard, Shirin; Dinh, Paul C; Monahan, Patrick O.; Fosså , Sophie; Huddart, Robert A; Fung, Chunkit; Song, Yiqing; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Martin, Neil E.; Kollmannsberger, Christian K.; Hou, Lifang; Einhorn, Lawrence; Kroenke, Kurt; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; National Advisory Unit on Late Effects After Cancer Treatment, Oslo, Norway; ; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Indiana University Richard M Fairbanks School of Public Health, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Department of Medicine, University of Pennsylvania, Philadelphia, PA; ; Dana Farber Cancer Institute, Boston, MA; ; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; ; Feinberg School of Medicine, Northwestern University, Chicago, IL; ; Indiana University Melvin and Bren S; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.5025-5025)
-
189
- Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
- Zhang, Xindi; Trendowski, Matthew R.; Wilkinson, Emma; Shahbazi, Mohammad; Dinh, Paul C.; Shuey, Megan M.; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian; Huddart, Robert; Martin, Neil E.; Sanchez, Victoria A.; Frisina, Robert D.; Einhorn, Lawrence H.; Cox, Nancy J.; Travis, Lois B.; Dolan, M. Eileen; Department of Medicine University of Chicago Chicago Illinois USA; Department of Medicine University of Chicago Chicago Illinois USA; Department of Medicine University of Chicago Chicago Illinois USA; Department of Medicine University of Chicago Chicago Illinois USA; Division of Medical Oncology Indiana University Indianapolis Indiana USA; Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA; Department of Medical Oncology Memorial Sloan‐ Kettering Cancer Center New York New York USA; Department of Surgical Oncology Princess Margaret Cancer Centre Toronto Ontario Canada; Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA; J.P. Wilmot Cancer Institute University of Rochester Medical Center Rocheste; (Cancer medicine, v.11, 2022, pp.2801-2816)
-
190
- Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments.
- Ardeshirrouhanifard, Shirin; Fosså , Sophie; Huddart, Robert A; Monahan, Patrick O.; Fung, Chunkit; Song, Yiqing; Dolan, M. Eileen; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Martin, Neil E.; Kollmannsberger, Christian K.; Dinh, Paul C; Hou, Lifang; Zheng, Yinan; Einhorn, Lawrence; Frisina, Robert D.; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; ; National Advisory Unit on Late Effects After Cancer Treatment, Oslo, Norway; ; Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; ; Indiana University School of Medicine, Indianapolis, IN; ; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY; ; Indiana University Richard M Fairbanks School of Public Health, Indianapolis, IN; ; Department of Medicine, University of Chicago, Chicago, IL; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Division of Urologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Department of Medicine, University of Pennsylvania, Philadelphia, PA; ; Dana Farber Cancer Institute, Boston, MA; ; Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; ; Indiana University School of Medicine, Indianapolis, IN; ; Feinberg School of Medicine, Northwestern U; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.39, 2021, pp.5016-5016)
QUICK MENU
